January 14, 2020
Partnership Underway to Develop Extensive Protocols and Submissions for US Food & Drug Administration to Uncover Safety and Efficacy for...
December 16, 2019
CB2 Insights announced that it will begin a prospective trial with GL Brands through its hemp brand and key operating...
December 12, 2019
CB2 Insights announced its core technology platform, Sail, is now primed for streamlining and aggregating disparate healthcare data systems.
December 11, 2019
CB2 Insights announces a warrant exercise incentive program which has been implemented to encourage the exercise of the Company’s outstanding...
December 3, 2019
CB2 Insights (CSE:CBII, OTCQB:CBIIF) announced that it is partnering with Licensed Producer FCM Global.
November 14, 2019
CB2 Insights today announced Prad Sekar, CEO of CB2 Insights will be participating in a panel discussion and meeting.
November 8, 2019
CB2 Insights (CSE:CBII; OTCQB:CBIIF) announces its results for the three and nine months ended September 30, 2019.